Altimmune Inc
NASDAQ:ALT
Altimmune Inc
NASDAQ:ALT
Price:
4.62
USD
1.09%
Market Closed
Market Cap:
$481.6m
Balance Sheet
Balance Sheet Decomposition
Altimmune Inc
Altimmune Inc
Balance Sheet Decomposition is not available for
Altimmune Inc
Altimmune Inc
Balance Sheet
Altimmune Inc
Altimmune Inc
Currency: USD
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
5
|
41
|
20
|
3
|
12
|
11
|
13
|
11
|
12
|
9
|
3
|
9
|
34
|
9
|
116
|
190
|
111
|
135
|
37
|
|
| Cash Equivalents |
1
|
5
|
41
|
20
|
3
|
12
|
11
|
13
|
11
|
12
|
9
|
3
|
9
|
34
|
9
|
116
|
190
|
111
|
135
|
37
|
|
| Short-Term Investments |
0
|
0
|
12
|
3
|
3
|
0
|
0
|
0
|
0
|
6
|
6
|
0
|
0
|
0
|
28
|
100
|
0
|
74
|
63
|
95
|
|
| Total Receivables |
0
|
2
|
5
|
10
|
19
|
9
|
7
|
7
|
4
|
0
|
2
|
1
|
10
|
5
|
2
|
12
|
6
|
3
|
5
|
3
|
|
| Accounts Receivables |
0
|
2
|
4
|
4
|
9
|
9
|
7
|
7
|
4
|
0
|
2
|
0
|
4
|
4
|
1
|
5
|
0
|
0
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
1
|
7
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
1
|
1
|
8
|
5
|
2
|
4
|
3
|
|
| Other Current Assets |
69
|
1
|
1
|
13
|
1
|
3
|
1
|
1
|
0
|
0
|
0
|
0
|
5
|
1
|
1
|
2
|
8
|
5
|
7
|
2
|
|
| Total Current Assets |
70
|
8
|
59
|
46
|
26
|
24
|
20
|
20
|
14
|
19
|
17
|
5
|
24
|
39
|
39
|
230
|
204
|
193
|
210
|
137
|
|
| PP&E Net |
0
|
5
|
7
|
5
|
6
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
2
|
|
| PP&E Gross |
0
|
5
|
7
|
5
|
6
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
2
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
2
|
3
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Intangible Assets |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
39
|
14
|
13
|
13
|
12
|
12
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
19
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
19
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
70
N/A
|
15
-79%
|
67
+350%
|
56
-15%
|
35
-37%
|
27
-23%
|
23
-16%
|
23
0%
|
17
-25%
|
22
+29%
|
20
-10%
|
38
+93%
|
63
+64%
|
55
-13%
|
54
-1%
|
245
+353%
|
219
-11%
|
207
-5%
|
211
+2%
|
139
-34%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
0
|
1
|
1
|
4
|
2
|
3
|
1
|
2
|
1
|
0
|
1
|
2
|
0
|
0
|
0
|
1
|
2
|
5
|
2
|
0
|
|
| Accrued Liabilities |
0
|
2
|
3
|
6
|
10
|
3
|
3
|
2
|
3
|
1
|
2
|
3
|
4
|
4
|
4
|
11
|
10
|
11
|
10
|
10
|
|
| Short-Term Debt |
0
|
12
|
0
|
13
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
4
|
4
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
8
|
2
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
1
|
0
|
0
|
|
| Total Current Liabilities |
0
|
14
|
9
|
36
|
14
|
6
|
5
|
8
|
7
|
3
|
2
|
6
|
4
|
5
|
4
|
12
|
18
|
17
|
12
|
10
|
|
| Long-Term Debt |
0
|
0
|
17
|
1
|
17
|
0
|
0
|
2
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
2
|
0
|
1
|
1
|
9
|
2
|
2
|
2
|
1
|
1
|
0
|
4
|
1
|
5
|
7
|
2
|
5
|
4
|
5
|
|
| Total Liabilities |
0
N/A
|
19
+4 700%
|
26
+35%
|
37
+44%
|
32
-14%
|
15
-53%
|
7
-53%
|
11
+59%
|
10
-12%
|
4
-62%
|
3
-14%
|
6
+94%
|
14
+132%
|
6
-56%
|
9
+33%
|
19
+126%
|
20
+3%
|
22
+10%
|
17
-23%
|
16
-4%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
0
|
65
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
70
|
87
|
124
|
155
|
190
|
194
|
199
|
210
|
220
|
224
|
31
|
78
|
117
|
137
|
186
|
293
|
378
|
466
|
561
|
|
| Additional Paid In Capital |
56
|
0
|
127
|
142
|
157
|
201
|
209
|
211
|
218
|
239
|
240
|
71
|
122
|
170
|
188
|
417
|
497
|
568
|
665
|
690
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
14
|
0
|
2
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
8
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Total Equity |
70
N/A
|
4
N/A
|
41
N/A
|
19
-53%
|
3
-83%
|
12
+281%
|
16
+30%
|
12
-26%
|
7
-38%
|
18
+151%
|
17
-9%
|
32
+94%
|
49
+51%
|
48
-1%
|
46
-6%
|
226
+396%
|
199
-12%
|
185
-7%
|
194
+5%
|
124
-36%
|
|
| Total Liabilities & Equity |
70
N/A
|
15
-79%
|
67
+350%
|
56
-15%
|
35
-37%
|
27
-23%
|
23
-16%
|
23
0%
|
17
-25%
|
22
+29%
|
20
-10%
|
38
+93%
|
63
+64%
|
55
-13%
|
54
-1%
|
245
+353%
|
219
-11%
|
207
-5%
|
211
+2%
|
139
-34%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
9
|
15
|
37
|
41
|
49
|
71
|
72
|
|
| Preferred Shares Outstanding |
0
|
62
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
